Welcome to LookChem.com Sign In|Join Free
  • or
(AC-CYS-OH)2, also known as N,N'-Diacetyl-L-cystine (DiNAC), is a disulfide dimer of N-acetylcysteine with immunomodulatory properties. Its intact disulfide bridge is crucial for its ability to modify contact sensitivity/delayed hypersensitivity reactions in mice.

5545-17-5

Post Buying Request

5545-17-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5545-17-5 Usage

Uses

Used in Pharmaceutical Industry:
(AC-CYS-OH)2 is used as a treatment for dermal inflammations caused by leukotriene production due to its immunomodulatory properties.
Used in Immunology Research:
(AC-CYS-OH)2 is used as a research tool for studying contact sensitivity/delayed hypersensitivity reactions in mice, providing insights into the mechanisms of immune response modulation.
Used in Cardiovascular Research:
(AC-CYS-OH)2 is used as a compound with anti-atherosclerotic effects, improving endothelial function in Watanabe heritable hyperlipidemic rabbits, which can contribute to the development of therapies for cardiovascular diseases.

Check Digit Verification of cas no

The CAS Registry Mumber 5545-17-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,5,4 and 5 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 5545-17:
(6*5)+(5*5)+(4*4)+(3*5)+(2*1)+(1*7)=95
95 % 10 = 5
So 5545-17-5 is a valid CAS Registry Number.
InChI:InChI=1/C10H16N2O6S2/c1-5(13)11-7(9(15)16)3-19-20-4-8(10(17)18)12-6(2)14/h7-8H,3-4H2,1-2H3,(H,11,13)(H,12,14)(H,15,16)(H,17,18)/t7-,8-/m0/s1

5545-17-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Sigma-Aldrich

  • (A0152000)  Acetylcysteine impurity C  European Pharmacopoeia (EP) Reference Standard

  • 5545-17-5

  • A0152000

  • 1,880.19CNY

  • Detail

5545-17-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name (AC-CYS-OH)2

1.2 Other means of identification

Product number -
Other names N-ACETYL CYSTINE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:5545-17-5 SDS

5545-17-5Synthetic route

N-acetylcystein
616-91-1

N-acetylcystein

N,N'-diacetyl-L-cystine
5545-17-5

N,N'-diacetyl-L-cystine

Conditions
ConditionsYield
With bis(4-methoxyphenyl)telluride; 5,15,10,20-tetraphenylporphyrin In dichloromethane; isopropyl alcohol at 0℃; for 0.25h; Irradiation;100%
With (bis(2,1-phenylene)bis(azanediyl)bis(methylene)diphenol)diselenide In water; acetonitrile at 20℃; for 7h;83%
With (+)-flavinophane Fl(7) In methanol; water at 30℃; Rate constant; pH 9.55; other (+)- and (-)-flavinophanes and 5-deazaflavinophanes; asymmetric discrimination;
L-Cysteine
52-90-4

L-Cysteine

acetic anhydride
108-24-7

acetic anhydride

N,N'-diacetyl-L-cystine
5545-17-5

N,N'-diacetyl-L-cystine

Conditions
ConditionsYield
With sodium hydroxide for 0.5h; Ambient temperature;22%
N,N'-diacetyl-L-cystine dimethyl ester
32381-28-5

N,N'-diacetyl-L-cystine dimethyl ester

N,N'-diacetyl-L-cystine
5545-17-5

N,N'-diacetyl-L-cystine

Conditions
ConditionsYield
durch Verseifung;
N,N'-diacetyl-L-cystine dipropyl ester
1033249-05-6

N,N'-diacetyl-L-cystine dipropyl ester

N,N'-diacetyl-L-cystine
5545-17-5

N,N'-diacetyl-L-cystine

Conditions
ConditionsYield
durch Verseifung;
L-cystine
56-89-3

L-cystine

acetic anhydride
108-24-7

acetic anhydride

N,N'-diacetyl-L-cystine
5545-17-5

N,N'-diacetyl-L-cystine

Conditions
ConditionsYield
With sodium hydroxide
With potassium hydroxide
N-acetylcystein
616-91-1

N-acetylcystein

A

N,N'-diacetyl-L-cystine
5545-17-5

N,N'-diacetyl-L-cystine

B

S-nitroso-N-acetylcysteine
56577-02-7

S-nitroso-N-acetylcysteine

Conditions
ConditionsYield
With hydrogenchloride; sodium nitrite at 25℃;A n/a
B 82 % Chromat.
N-acetylcystein
616-91-1

N-acetylcystein

A

N,N'-diacetyl-L-cystine
5545-17-5

N,N'-diacetyl-L-cystine

B

(R)-2-Acetylamino-3-((R)-2-acetylamino-2-carboxy-ethylsulfanyl)-propionic acid

(R)-2-Acetylamino-3-((R)-2-acetylamino-2-carboxy-ethylsulfanyl)-propionic acid

Conditions
ConditionsYield
With water Quantum yield; Mechanism; γ-radiation (radiolysis); also with NaN3;
N-acetylcystein
616-91-1

N-acetylcystein

S-nitroso-N-acetylcysteine
56577-02-7

S-nitroso-N-acetylcysteine

N,N'-diacetyl-L-cystine
5545-17-5

N,N'-diacetyl-L-cystine

Conditions
ConditionsYield
In water at 25℃; Rate constant; also in the presence of var. conc. of EDTA;
N.N'-diacetyl-DL-cystine

N.N'-diacetyl-DL-cystine

N,N'-diacetyl-L-cystine
5545-17-5

N,N'-diacetyl-L-cystine

Conditions
ConditionsYield
With brucine durch Zerlegung;
S-nitroso-N-acetylcysteine
56577-02-7

S-nitroso-N-acetylcysteine

N,N'-diacetyl-L-cystine
5545-17-5

N,N'-diacetyl-L-cystine

Conditions
ConditionsYield
In water at 25℃; for 19.6667h; Quantum yield; Kinetics; Further Variations:; Solvents; also in the dark; Dimerization; UV-irradiation;
With ethylenediaminetetraacetic acid; hydroxide In water Kinetics; Further Variations:; pH dependence; Radiolysis;
With sodium hydrogen sulfide In water Acidic conditions;
With Cu2O
N-acetylcystein
616-91-1

N-acetylcystein

trans,trans,trans-[PtCl2(OH)2(c-C6H11NH2)(NH3)]
124721-03-5, 1313200-52-0, 146924-11-0

trans,trans,trans-[PtCl2(OH)2(c-C6H11NH2)(NH3)]

A

N,N'-diacetyl-L-cystine
5545-17-5

N,N'-diacetyl-L-cystine

trans-[Pt(OH)2(c-C6H11NH2)(NH3)]
1034767-14-0

trans-[Pt(OH)2(c-C6H11NH2)(NH3)]

Conditions
ConditionsYield
In water Kinetics; react. with N-acetyl-L-cysteine at pH 9 at 25°C;
dopamine
51-61-6

dopamine

N-acetylcystein
616-91-1

N-acetylcystein

A

N,N'-diacetyl-L-cystine
5545-17-5

N,N'-diacetyl-L-cystine

B

2-S-(N-acetyl)-cysteinyl-dopamine

2-S-(N-acetyl)-cysteinyl-dopamine

C

5-S-(N-acetyl)-cysteinyl-dopamine

5-S-(N-acetyl)-cysteinyl-dopamine

D

2-S-5-S-di-(N-acetyl)-cysteinyl-dopamine

2-S-5-S-di-(N-acetyl)-cysteinyl-dopamine

Conditions
ConditionsYield
Stage #1: dopamine With dihydrogen peroxide; lactoperoxidase at 25℃; pH=7.5; aq. phosphate buffer; Enzymatic reaction;
Stage #2: N-acetylcystein at 20℃; for 0.166667h; pH=7.5; aq. phosphate buffer;
N-acetylcystein
616-91-1

N-acetylcystein

A

N,N'-diacetyl-L-cystine
5545-17-5

N,N'-diacetyl-L-cystine

B

C4H9NO2*BrH

C4H9NO2*BrH

Conditions
ConditionsYield
With C(13)C4H8AuBr2(15)NO2S2 In dimethylsulfoxide-d6 for 4h;
(R)-2-[3,5-Bis-((R)-1-carboxy-2-mercapto-ethylcarbamoyl)-benzoylamino]-3-mercapto-propionic acid
858675-87-3

(R)-2-[3,5-Bis-((R)-1-carboxy-2-mercapto-ethylcarbamoyl)-benzoylamino]-3-mercapto-propionic acid

N-acetylcystein
616-91-1

N-acetylcystein

(2S,2'S)-N1,N1’-(1,3-phenylene)bis(2-(2-mercaptoacetamido)succinamide)
1597415-37-6

(2S,2'S)-N1,N1’-(1,3-phenylene)bis(2-(2-mercaptoacetamido)succinamide)

A

N,N'-diacetyl-L-cystine
5545-17-5

N,N'-diacetyl-L-cystine

B

C28H38N8O12S4

C28H38N8O12S4

C

C33H42N6O18S6

C33H42N6O18S6

D

C41H48N10O18S6

C41H48N10O18S6

Conditions
ConditionsYield
In dimethyl sulfoxide at 20℃; for 24h; pH=6.5;
ethanol
64-17-5

ethanol

N,N'-diacetyl-L-cystine
5545-17-5

N,N'-diacetyl-L-cystine

N,N'-diacetyl-L-cystine diethyl ester
24037-21-6

N,N'-diacetyl-L-cystine diethyl ester

Conditions
ConditionsYield
With sulfuric acid
N,N'-diacetyl-L-cystine
5545-17-5

N,N'-diacetyl-L-cystine

potassium cyanide
151-50-8

potassium cyanide

(4R)-3-acetyl-2-imino-thiazolidine-4-carboxylic acid
142582-26-1

(4R)-3-acetyl-2-imino-thiazolidine-4-carboxylic acid

Conditions
ConditionsYield
With water anschliessend mit wss. H2O2 behandeln;
N,N'-diacetyl-L-cystine
5545-17-5

N,N'-diacetyl-L-cystine

L-cystine
56-89-3

L-cystine

Conditions
ConditionsYield
With n-HCl
N,N'-diacetyl-L-cystine
5545-17-5

N,N'-diacetyl-L-cystine

N,N'-diacetyl-DL-cystine
5545-17-5, 97247-12-6, 139602-29-2

N,N'-diacetyl-DL-cystine

Conditions
ConditionsYield
With acetic anhydride; acetic acid at 27℃; entsteht Gemisch von racem. und meso-N.N'-Diacetyl-cystin;
N,N'-diacetyl-L-cystine
5545-17-5

N,N'-diacetyl-L-cystine

N,N'-diacetyl-L-cystine dimethyl ester
32381-28-5

N,N'-diacetyl-L-cystine dimethyl ester

Conditions
ConditionsYield
In methanol; diethyl ether
N,N'-diacetyl-L-cystine
5545-17-5

N,N'-diacetyl-L-cystine

methylamine
74-89-5

methylamine

N,N'-diacetyl-L-cystine bismethylamide
13028-62-1

N,N'-diacetyl-L-cystine bismethylamide

Conditions
ConditionsYield
(i) CH2N2, Et2O, (ii) ClCO2Et, N-methylmorpholine, THF, (iii) /BRN= 741851/, H2O; Multistep reaction;
N,N'-diacetyl-L-cystine
5545-17-5

N,N'-diacetyl-L-cystine

N-acetyl-S-bromo-L-cysteine

N-acetyl-S-bromo-L-cysteine

Conditions
ConditionsYield
With bromine In dichloromethane; acetic acid at 0℃;
N,N'-diacetyl-L-cystine
5545-17-5

N,N'-diacetyl-L-cystine

enzyme-substance from rats liver

enzyme-substance from rats liver

ammonia
7664-41-7

ammonia

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: n-HCl
2: hydrochloric acid
View Scheme
Multi-step reaction with 2 steps
1: n-HCl
2: hydrochloric acid
View Scheme
N,N'-diacetyl-L-cystine
5545-17-5

N,N'-diacetyl-L-cystine

L-cystine
6020-39-9

L-cystine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: n-HCl
2: hydrochloric acid
View Scheme
N,N'-diacetyl-L-cystine
5545-17-5

N,N'-diacetyl-L-cystine

DL-cystine
923-32-0

DL-cystine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: n-HCl
2: hydrochloric acid
View Scheme
N,N'-diacetyl-L-cystine
5545-17-5

N,N'-diacetyl-L-cystine

(R)-N-[2-mercapto-1-(3-methyl-1,2,4-oxadiazol-5-yl)-ethyl]-acetamide

(R)-N-[2-mercapto-1-(3-methyl-1,2,4-oxadiazol-5-yl)-ethyl]-acetamide

5545-17-5Relevant academic research and scientific papers

On N-acetylcysteine. Part I. Experimental and theoretical approaches of the N-acetylcysteine/H2O2 complexation

Arroub,Berges,Abedinzadeh,Langlet,Gardes-Albert

, p. 2094 - 2101 (1994)

The complexation of N-acetylcysteine (RSH) with hydrogen peroxide has been studied experimentally and theoretically. Experimentally we have measured the evolution of RSH, H2O2, and RSSR (N-acetylcystine) as a function of time. Surprisingly, H2O2 decays by a biphasic process, which is not the case for RSH and RSSR. In the first stage of the kinetics, H2O2 disappears without oxidizing the thiol function of RSH. By analogy with glutathione (GSH), the formation of a complex between RSH and H2O2 has been proposed. The thermodynamic equilibrium constant of complex formation has been determined. Theoretical calculations were performed within the SIBFA method to pinpoint the sites of complexation in isolated and hydrated states. A mixed 'discrete-continuum' model was used to evaluate the solvent effect. The two stable complexes found in isolated state have different behaviour under the influence of the solvent. Comparison with complexed GSH is discussed.

A kinetic analysis of oxidation of the antioxidant N-acetyl-l-cysteine (NAC) by Pt(IV) complexes

You, Daofeng,Ren, Yanli,Huo, Shuying,Dong, Jingran,Ren, Shuguang,Shi, Tiesheng

, p. 295 - 304 (2016)

N-acetyl-l-cysteine (NAC) is an antioxidant and a supplement and has been demonstrated to have protective effects for a variety of toxic effects of heavy metals. Although previous works have shown that NAC can ameliorate the severe toxic effects of cisplatin, there is a lack of understanding of the interactions between NAC and Pt(IV)-based prodrugs. In this work, the oxidation of NAC by a cisplatin prodrug (cis-[Pt(NH3)2Cl4]), by a prototype of Pt(IV) anticancer drug ormaplatin ([Pt(dach)Cl4]) and by a model compound (trans-[PtCl2(CN)4]2-) was characterized in detail. NAC was oxidized to NAC-disulfide as identified by mass spectrometric analysis. Time-resolved spectral and stopped-flow kinetic measurements were carried out over a wide pH range, demonstrating that the oxidation followed overall second-order kinetics. The observed second-order rate constants k′ versus pH profiles were established. A reaction mechanism was deduced, involving three parallel rate-determining steps; conceivable transition states were also proposed for these steps. Rate constants of the rate-determining steps, obtained from the simulations of rate equation to the k′-pH profiles, were largely correlated with the electron density on the sulfur atom in NAC. The Pt(IV) prodrugs can execute oxidative stress in the biological systems of the human body by direct oxidation of relevant molecules, similar to HOCl/OCl- and chloroamines. Instead, the oxidative stress involved in the severe toxic effects of cisplatin is produced via a different mode. NAC could be a chemoprotecting agent also for the Pt(IV) anticancer drugs if recent drug delivery technologies are used.

Entropy-Controlled Cu(II)-Catalyzed Oxidation of N-Acetyl-L-Cysteine by Methylene Blue in Acidic Medium

Sharma, Ranjana,Pal, Mahender,Mishra

, p. 1093 - 1109 (2017)

Kinetics of the oxidation of N-acetyl-L-cysteine (NAC) by methylene blue (MB) catalyzed by Cu(II) have been investigated in presence of HCl. The reaction follows a first order kinetics in MB while the concentration order in NAC is zero. Hydrogen ions retard the rate of reaction. The reaction involves the participation of nanoparticles as revealed by SEM, XRD and FTIR techniques and a gel-like Cu-NAC network acts like the effective catalyst. The reaction conforms to Eley-Rideal mechanism at lower [NAC] while at higher [NAC], the kinetics are explained by extended Eley-Rideal mechanism. The reaction is regulated by the size and morphology of the nanoparticles and is controlled by the entropy of activation.

Electrochemical Evidence in Mechanism of Toxicity of Mefenamic Acid Overdose in the Presence of Glutathione and N-Acetyl-L-Cysteine

Amani, Ameneh,Amooshahi, Parvaneh,Khazalpour, Sadegh

, (2020)

In this study, the electrochemical oxidation of mefenamic acid was investigated in the presence of glutathione and N-acetyl-L-cysteine. The results revealed that the mefenamic acid was involved in a catalytic reaction with glutathione and N-acetyl-L-cysteine. This investigation presents some electrochemical evidence for the mechanism of action of these compounds in mefenamic acid poisoning.

Enhanced Cellular Polysulfides Negatively Regulate TLR4 Signaling and Mitigate Lethal Endotoxin Shock

Zhang, Tianli,Ono, Katsuhiko,Tsutsuki, Hiroyasu,Ihara, Hideshi,Islam, Waliul,Akaike, Takaaki,Sawa, Tomohiro

, p. 686 - 4,698 (2019)

Cysteine persulfide and cysteine polysulfides are cysteine derivatives having sulfane sulfur atoms bound to cysteine thiol. Accumulating evidence has suggested that cysteine persulfides/polysulfides are abundant in prokaryotes and eukaryotes and play important roles in diverse biological processes such as antioxidant host defense and redox-dependent signal transduction. Here, we show that enhancement of cellular polysulfides by using polysulfide donors developed in this study resulted in marked inhibition of lipopolysaccharide (LPS)-initiated macrophage activation. Polysulfide donor treatment strongly suppressed LPS-induced pro-inflammatory responses in macrophages by inhibiting Toll-like receptor 4 (TLR4) signaling. Other TLR signaling stimulants—including zymosan A-TLR2 and poly(I:C)-TLR3—were also significantly suppressed by polysulfur donor treatment. Administration of polysulfide donors protected mice from lethal endotoxin shock. These data indicate that cellular polysulfides negatively regulate TLR4-mediated pro-inflammatory signaling and hence constitute a potential target for inflammatory disorders. Zhang et al. developed potent persulfide donors consisting of sulfane sulfur atoms stabilized by N-acetyl-L-cysteine (NAC polysulfides) via disulfide bonds at both sides. Strong anti-inflammatory activity of NAC polysulfides was demonstrated in cultured macrophage models and a mouse endotoxin shock model.

Insights into the reactivity of gold-dithiocarbamato anticancer agents toward model biomolecules by using multinuclear NMR spectroscopy

Boscutti, Giulia,Marchio, Luciano,Ronconi, Luca,Fregona, Dolores

, p. 13428 - 13436 (2013)

Some gold(III)-dithiocarbamato derivatives of either single amino acids or oligopeptides have shown promise as potential anticancer agents, but their capability to interact with biologically relevant macromolecules is still poorly understood. We investigated the affinity of the representative complex [Au IIIBr2(dtc-Sar-OCH3)] (dtc: dithiocarbamate; Sar: sarcosine (N-methylglycine)) with selected model molecules for histidine-, methionine-, and cysteine-rich proteins (that is, 1-methylimidazole, dimethylsulfide, and N-acetyl-L-cysteine, respectively). In particular, detailed mono- and multinuclear NMR studies, in combination with multiple 13C/15N enrichments, allowed interactions to be followed over time and indicated somewhat unexpected reaction pathways. Whereas dimethylsulfide proved to be unreactive, a sudden multistep redox reaction occurred in the presence of the other potential sulfur donor, N-acetyl-L-cysteine (confirmed if glutathione was used instead). On the other hand, 1-methylimidazole underwent an unprecedented acid-base reaction with the gold(III) complex, rather than the expected coordination to the metal center by replacing, for instance, a bromide. Our results are discussed herein and compared with the data available in the literature on related complexes; our findings confirm that the peculiar reactivity of gold(III)-dithiocarbamato complexes can lead to novel reaction pathways and, therefore, to new cytotoxic mechanisms in cancer cells. To react or not to react? Model nitrogen- and sulfur-donor compounds can be treated with a representative gold(III)- dithiocarbamato anticancer agent to evaluate potential reactivity of such anticancer agents toward biomolecules (see figure). Detailed NMR studies show that the interaction with physiologically relevant species can lead to unexpected reaction pathways that may contribute to the novel mechanisms of cytotoxicity observed for this class of complexes. Copyright

On N-acetylcysteine. Part II. Oxidation of N-acetylcysteine by hydrogen peroxide: Kinetic study of the overall process

Abedinzadeh,Arroub,Gardes-Albert

, p. 2102 - 2107 (1994)

The oxidation kinetics of N-acetylcysteine (RSH) by hydrogen peroxide has been studied at neutral pH at different concentration ratios from 0.2 to 20 (4 x 10-4 mol L-1 ≤ [RSH]0 ≤ 2 x 10- mol L-1, 10-4 mol L-1 ≤ [H2O2]0 ≤ 10-2 mol L-1). In all the cases studied, N-acetyleystine (RSSR) is the only oxidized product formed. Our kinetic data have focused on the importance of the concentration ratio to reach the stoichiometric oxidation of N-acetylcysteine by hydrogen peroxide. Indeed non-stoichiometric oxidation of RSH occurs at relatively low concentration ratios (R 2.5. Moreover, it has been shown that in the first minutes of the reaction there is the formation of a complex between RSH and H2O2, the stoichiometry of the complex being RSH concentration-dependent for a given R (R > 2.5). Reaction mechanisms have been quantitatively established and the k values of each step determined.

Efficient Amino-Sulfhydryl Stapling on Peptides and Proteins Using Bifunctional NHS-Activated Acrylamides

Silva, Maria J. S. A.,Faustino, Hélio,Coelho, Jaime A. S.,Pinto, Maria V.,Fernandes, Adelaide,Compa?ón, Ismael,Corzana, Francisco,Gasser, Gilles,Gois, Pedro M. P.

supporting information, p. 10850 - 10857 (2021/04/15)

Widely used reagents in the peptide functionalization toolbox, Michael acceptors and N-hydroxysuccinimide (NHS) activated esters, are combined in NHS-activated acrylamides for efficient chemoselective amino-sulfhydryl stapling on native peptides and proteins. NHS-activated acrylamides allow for a fast functionalization of N-terminal cysteines (k2=1.54±0.18×103 M?1 s?1) under dilute aqueous conditions, enabling selectivity over other nucleophilic amino acids. Additionally, the versatility of these new bioconjugation handles was demonstrated in the cross-linking of in-chain or C-terminal cysteines with nearby lysine residues. NHS-activated acrylamides are compatible with the use of other cysteine selective reagents, allowing for orthogonal dual-modifications. This strategy was successfully applied to the late-stage functionalization of peptides and proteins with a PEG unit, fluorescent probe, and cytotoxic agent. The level of molecular control offered by NHS-activated acrylamides is expected to promote amino-sulfhydryl stapling technology as a powerful strategy to design functional bioconjugates.

PROCESS OF MAKING N,N'-DIACETYL-L-CYSTINE

-

Page/Page column 16-17, (2021/11/06)

An effective process of making Ν,Ν'-diacetyl-L-Cystine ( NDAC ), which process is fast, green, does not require labor-intensive isolation or purification of the product, by yielding products in desired ratio, and has improved yield and purity. The process comprising the steps of Forming a reaction mixture, starting with a cystine derivative di-tert- butyl-L-cystine as the dihydrochloride form; Acetylating said di-tert-butyl-L-cystine to obtain Ν,Ν'-diacetyl-di-tert- butyl-L-cystine; followed by Removing said tert- butyl groups from said Ν,Ν'-diacetyl-di-tert-butyl- L-cystine to obtain Ν,Ν'-diacetyl-L-cystine product; and Isolating said Ν,Ν'-diacetyl-L-Cystine product from said reaction mixture; wherein said acetylating agent is acetic anhydride.

Bacterial flavoprotein monooxygenase YxeK salvages toxic S-(2-succino)-adducts via oxygenolytic C–S bond cleavage

Ellis, Holly R.,Kammerer, Bernd,Lagies, Simon,Matthews, Arne,Sch?nfelder, Julia,Schleicher, Erik,Stull, Frederick,Teufel, Robin

, (2021/10/06)

Thiol-containing nucleophiles such as cysteine react spontaneously with the citric acid cycle intermediate fumarate to form S-(2-succino)-adducts. In Bacillus subtilis, a salvaging pathway encoded by the yxe operon has recently been identified for the detoxification and exploitation of these compounds as sulfur sources. This route involves acetylation of S-(2-succino)cysteine to N-acetyl-2-succinocysteine, which is presumably converted to oxaloacetate and N-acetylcysteine, before a final deacetylation step affords cysteine. The critical oxidative cleavage of the C–S bond of N-acetyl-S-(2-succino)cysteine was proposed to depend on the predicted flavoprotein monooxygenase YxeK. Here, we characterize YxeK and verify its role in S-(2-succino)-adduct detoxification and sulfur metabolism. Detailed biochemical and mechanistic investigation of YxeK including 18O-isotope-labeling experiments, homology modeling, substrate specificity tests, site-directed mutagenesis, and (pre-)steady-state kinetics provides insight into the enzyme’s mechanism of action, which may involve a noncanonical flavin-N5-peroxide species for C–S bond oxygenolysis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 5545-17-5